A team of scientists and engineers, led at the Massachusetts General Hospital Diabetes Center by Steven Russell, MD, PhD, have developed and are testing a first-of-its-kind automated device with the potential to revolutionize diabetes treatment. This medical breakthrough is called the bionic pancreas – and it’s closer than ever to making a real world impact on patients.
Endocrinologist Steven Russell, MD, PhD, of the Mass General Diabetes Center, and Edward Damiano, PhD, associate professor of biomedical engineering at Boston University, spent part of their summer at Camp Joslin, a summer camp for children with diabetes in western […]
The bionic pancreas is a prototype device designed to reduce the constant burden of monitoring and adjusting blood sugar levels for the millions of people with diabetes.
Genetics can help predict the risk for type 2 diabetes, but MGH researcher Jose C. Florez, MD, PhD, says exercise and diet can still prevent the disease.
Jose Florez, MD, PhD, MGH Diabetes Center Endocrinologist and MGH Research Scholar, gives a talk on the human genome and its potential to improve care for people with type 2 diabetes in “Genetics Matters” as part of the May […]
Is it possible to predict someone’s risk of getting type 2 diabetes a dozen years before symptoms appear? Massachusetts General Hospital researcher Robert E. Gerszten, MD, recently told Fox 25 TV Boston about a groundbreaking study he and his colleagues […]
Amid pressures to cut costs, Mass General must focus its commitment to excellence and innovation on finding ways to more economically deliver the world-class care for which it is known.